Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 23, 2024Journal of Advances in Medicine and Medical Research

Effectiveness of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors in Reducing Cardiovascular Mortality in Heart Failure: Systematic Review and Meta-Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

AMArhum MahmoodMAMarium AbidRRRubela Ray

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mahmood et al. (2024) studied this question.

synapsesocial.com/papers/68e57adfb6db64358751a317https://doi.org/10.9734/jammr/2024/v36i105599
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Effects of Sodium-Glucose Co-transporter 2 Inhibitors on Cardiovascular Outcomes in Heart Failure: A Systematic Review and Meta-Analysis2025
  2. 2The Role of SGLT2 Inhibitors in Heart Failure: A Systematic Review and Meta-Analysis2021 · 40 citations
  3. 3Impact of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) on Cardiovascular Outcomes in Heart Failure With Reduced Ejection Fraction Under Contemporary Standard Care: A Systematic Review and Meta-Analysis2025
  4. 4Effectiveness of SGLT2 inhibitor therapy in treatment of Heart failure: A Meta-Analysis2023
  5. 5Cardiovascular outcomes and safety assessment of SGLT2i on heart failure patients: a systematic review and meta-analysis2025 · 1 citations